Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chutes and Ladders
Biotech
Xaira, Anthos, CureVac & more—Chutes & Ladders
Ousted former Stanford president to lead new billion-dollar biotech. Fresh off BMS buy, Karuna’s ex-CEO to helm Anthos. CureVac names new CBO.
Max Bayer
,
Gabrielle Masson
,
Andrea Park
Apr 26, 2024 8:30am
How Vir found the one: CEO Marianne De Backer
Apr 19, 2024 10:27am
Recursion, Canaan, Metsera and more—Chutes & Ladders
Apr 19, 2024 8:30am
BIO, Seaport, Orna and more—Chutes & Ladders
Apr 12, 2024 8:30am
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
No reprieve for biopharma layoffs in Q1: Fierce Biotech analysis
Apr 1, 2024 10:43am